Open Journal of Veterinary Medicine

Volume 2, Issue 2 (June 2012)

ISSN Print: 2165-3356   ISSN Online: 2165-3364

Google-based Impact Factor: 1.1  Citations  h5-index & Ranking

Evaluation of Mast Cells in Dermal versus Subcutaneous Hemangiomas and Hemangiosarcomas in Dogs

HTML  Download Download as PDF (Size: 268KB)  PP. 60-65  
DOI: 10.4236/ojvm.2012.22010    6,192 Downloads   10,185 Views  Citations

ABSTRACT

This study investigated the role of mast cells in canine cutaneous vascular tumors, and is the first such study to distinguish between tumors arising in the dermis versus the subcutis. Mast cell numbers in canine cutaneous hemangiomas (HA) and hemangiosarcomas (HSA) were evaluated to identify a relationship between mast cells, tumor type (HA, HSA), histologic location (dermis, subcutis) and tumor recurrence. One hundred and sixty-seven biopsies from 148 dogs were evaluated. Using only one biopsy from each dog, mast cell counts (MCC) for each tumor (n = 148) were obtained by averaging the number of mast cells counted in ten 400× fields. A significant difference in mean MCC was found only between tumor types, with HA having more mast cells than HSA (4.2 ± 4.2 vs. 2.2 ± 2.6; p < 0.001). No significant difference in mean MCC existed between tumors that recurred and those that did not. There was no difference in recurrence rate between tumor type or histologic location. Our results indicate that benign HA contain more mast cells than malignant endothelial cell tumors, regardless of histologic location; whether this is a cause or effect relationship remains to be determined.

Share and Cite:

K. Barber, K. Newkirk, A. Reed and R. Donnell, "Evaluation of Mast Cells in Dermal versus Subcutaneous Hemangiomas and Hemangiosarcomas in Dogs," Open Journal of Veterinary Medicine, Vol. 2 No. 2, 2012, pp. 60-65. doi: 10.4236/ojvm.2012.22010.

Copyright © 2021 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.